0000899243-20-026184.txt : 20200923
0000899243-20-026184.hdr.sgml : 20200923
20200923190552
ACCESSION NUMBER: 0000899243-20-026184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200921
FILED AS OF DATE: 20200923
DATE AS OF CHANGE: 20200923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CureDuchenne Ventures, LLC
CENTRAL INDEX KEY: 0001824590
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201193105
BUSINESS ADDRESS:
STREET 1: 1400 QUAIL STREET
STREET 2: SUITE 110
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: 949-872-2552
MAIL ADDRESS:
STREET 1: 1400 QUAIL STREET
STREET 2: SUITE 110
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-21
1
0001818794
Dyne Therapeutics, Inc.
DYN
0001824590
CureDuchenne Ventures, LLC
1400 QUAIL STREET SUITE 110
NEWPORT BEACH
CA
92660
0
0
1
0
Common Stock
2020-09-21
4
C
0
602972
A
602972
D
Series A Preferred Stock
2020-09-21
4
C
0
2000000
0.00
D
Common Stock
602972
0
D
On September 21, 2020, the Series A Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
CureDuchenne Ventures, LLC, By: /s/ Debra Miller, Chief Executive Officer
2020-09-23